278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer
oleh: Victor Moreno, Ramaswamy Govindan, George Blumenschein, Siddhartha Devarakonda, Melissa Johnson, Carlos Bachier, Bernard Doger de Spéville, Vincent Lam, Natalie Hyland
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.